Abbvie Inc.
ABBV
Revenue
14.46B
▲2.15B▲17.48%
3 Months ChangeAssets
141.94B
▼-6.94B▼-4.66%
3 Months ChangeLiabilities
135.16B
▼-5.71B▼-4.05%
3 Months ChangeFree Cash Flow
3.85B
▼-171.00M▼-4.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001551152-24-000036
2024-10-03
Form 8-K
ID: 0001551152-24-000033
2024-09-10
Form 8-K
ID: 0001104659-24-098564
2024-08-07
Form 10-Q
ID: 0001551152-24-000031
2024-07-25
Form 8-K
ID: 0001551152-24-000026
2024-07-03
Form 8-K
ID: 0001551152-24-000024
2024-05-03
Form 10-Q
ID: 0001551152-24-000020
2024-04-26
Form 8-K
ID: 0001551152-24-000016
2024-04-03
Form 8-K
ID: 0001551152-24-000013
2024-02-26
Form 8-K
ID: 0001104659-24-027585